Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA

OBJECTIVES: To avoid the significant risks posed by the use of COVID-19 serology tests with supply chain constraints or poor performance characteristics, we developed an in-house SARS-CoV-2 total antibody test. Our test was compared with three commercial methods, and was used to determine COVID-19 s...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Stefani N., Altawallbeh, Ghaith, Zaun, Christopher P., Pape, Kathryn A., Peters, Jennifer M., Titcombe, Philip J., Dileepan, Thamotharampillai, Rapp, Michael J., Bold, Tyler D., Schacker, Timothy W., Arbefeville, Sophie, Ferrieri, Patricia, Thyagarajan, Bharat, Jenkins, Marc K., Karger, Amy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849522/
https://www.ncbi.nlm.nih.gov/pubmed/33539808
http://dx.doi.org/10.1016/j.clinbiochem.2021.01.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849522/
https://www.ncbi.nlm.nih.gov/pubmed/33539808
http://dx.doi.org/10.1016/j.clinbiochem.2021.01.010

Ejemplares similares